Source of elastin-degrading enzymes in mycotic aortic aneurysms: Bacteria or host inflammatory response?

Cardiovascular Surgery

Volumn 7, Issue 1, 1999, Pages 16-26

  Buckmaster, M J ^a   Curci, J A ^a   Murray, P R ^a   Liao, S ^a   Allen, B T ^a   Sicard, G A ^a   Thompson, R W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elastases; Elastin; Human neutrophil elastase; Mycotic aortic aneurysm; Polymorphonuclear neutrophils; Pseudomonas aeruginosa

Indexed keywords

BENZYLSULFONYL FLUORIDE; EDETIC ACID; ELASTASE; ELASTIN; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

AGED; ARTICLE; BINDING AFFINITY; CASE REPORT; CONTROLLED STUDY; ENZYME ISOLATION; ENZYME KINETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYCOTIC ANEURYSM; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA;

EID: 0032959455     PISSN: 09672109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-2109(98)00099-4     Document Type: Article

References (64)

1. Rucker R. B., Tinker D. Structure and metabolism of arterial elastin. International Reviews in Experimental Pathology. 17:1977;1-47.
2. Mecham R. P. Elastin synthesis and fiber assembly. Annals of the New York Academy of Science. 624:1991;137-146.
3. Lefevre M., Rucker R. B. Aortic elastin turnover in normal and hypercholesterolemic Japanese quail. Biochimica et Biophysica Acta. 630:1980;519-529.
4. Shapiro S. D., Endocott S. K., Province M. A.et al. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. Journal of Clinical Investigation. 87:1991;1828-1834.
5. Zatina M. A., Zarins C. K., Gewertz B. L., Glagov S. Role of medial lamellar architecture in the pathogenesis of aortic aneurysms. Journal of Vascular Surgery. 1:1984;442-448.
6. Campa J. S., Greenhalgh R. M., Powell J. T. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis. 65:1987;13-21.
7. Tilson M. D. Histochemistry of aortic elastin in nonspecific abdominal aortic aneurysm disease. Archives of Surgery. 123:1988;503-505.
8. Powell, J. T., Dilatation through loss of elastin. In The Cause and Management of Aneurysms, ed. R. M. Greenhalgh, J. A. Mannick and J. T. Powell. W. B. Saunders, London, 1990, pp. 89-96.
9. White J. V., Haas K., Phillips S., Comerota A. J. Adventitial elastolysis is a primary event in aneurysm formation. Journal of Vascular Surgery. 17:1993;371-381.
10. He C. M., Roach M. R. The composition and mechanical properties of abdominal aortic aneurysms. Journal of Vascular Surgery. 20:1994;6-13.
11. Dobrin P. B., Baker W. H., Gley W. C. Elastolytic and collagenolytic studies of arteries: implications for the mechanical properties of aneurysms. Archives of Surgery. 119:1984;405-409.
12. Dobrin P. B., Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovascular Surgery. 2:1994;484-488.
13. Anidjar S., Salzmann J. L., Gentric D.et al. Elastase-induced experimental aneurysms in rats. Circulation. 82:1990;973-981.
14. Gandhi R. H., Irizarry E., Cantor J. O.et al. Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. Surgery. 115:1994;617-620.
15. Busuttil R., Rinderbriecht H., Flecher A., Carnack C. Elastase activity: the role of elastase in aortic aneurysm formation. Journal of Surgical Research. 32:1982;214-217.
16. Cohen J. R., Mandell C., Chang J. B., Wise L. Elastin metabolism of the infrarenal aorta. Journal of Vascular Surgery. 7:1988;210-214.
17. Reilly J. M., Brophy C. M., Tilson M. D. Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin. Annals of Vascular Surgery. 6:1992;499-502.
18. Thompson R. W., Holmes D. R., Mertens R. A.et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. Journal of Clinical Investigation. 96:1995;318-326.
19. Curci J. A., Olin J., Liao S.et al. Human macrophage metalloelastase is produced in abdominal aortic aneurysms and localized to its matrix substrate. FASEB Journal. 11(3):1997;A336.
20. Thompson R. W. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Current Opinion in Cardiology. 11:1996;504-518.
21. Grange J. J., Davis V., Baxter B. T. Pathogenesis of abdominal aortic aneurysm: update and look toward the future. Cardiovascular Surgery. 5(3):1997;256-265.
22. Crawford, E. S. and Crawford, J. L., Aortic Infection. In Diseases of the Aorta: An Atlas of Angiographic Pathology and Surgical Technique, ed. E. S. Crawford and J. L. Crawford. Williams and Wilkins, Baltimore, 1984, pp. 340-376.
23. Brown S. L., Busuttil R. W., Baker J. D.et al. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. Journal of Vascular Surgery. 1:1984;541-547.
24. Chan F. Y., Crawford E. S., Coselli J. S.et al. In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Annals of Thoracic Surgery. 47:1989;193-203.
25. Atnip R. G. Mycotic aneurysms of the suprarenal abdominal aorta: prolonged survival after in situ aortic and visceral reconstruction. Journal of Vascular Surgery. 10:1989;635-641.
26. Cull D. L., Winter R. P., Wheeler J. R.et al. Mycotic aneurysm of the suprarenal aorta. Journal of Cardiovascular Surgery. 33:1992;181-184.
27. Gomes M. N., Choyke P. L., Wallace R. B. Infected aortic aneurysms: a changing entity. Annals of Surgery. 215:1992;435-442.
28. Fichelle J. M., Tabet G., Cormier P.et al. Infected infrarenal aortic aneurysms: when is in situ reconstruction safe? Journal of Vascular Surgery. 17:1993;635-645.
29. Chan P., Tsai C. W., Huang J. J.et al. Salmonellosis and mycotic aneurysm of the aorta: a report of 10 cases. Journal of Infection. 30:1995;129-133.
30. Chiba Y., Muraoka R., Ihaya A.et al. Surgical treatment of infected thoracic and abdominal aortic aneurysms. Cardiovascular Surgery. 4:1996;476-479.
31. Banda, M. J., Dovey, H. F. and Werb, Z., Elastinolytic enzymes. In Methods For Studying Mononuclear Phagocytes, ed. D. O. Adams, P. J. Edelson and H. Koren Academic Press, New York, 1981, pp. 603-618.
32. Senior R. M., Connolly N. L., Cury J. D.et al. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. American Review of Respiratory Disease. 139:1989;1251-1256.
33. Senior R. M., Griffin G. L., Fliszar C. J.et al. Human 92- and 72-kildodalton type IV collagenases are elastases. Journal of Biological Chemistry. 266:1991;7870-7875.
34. Armitage, P. and Berry, G., Statistical Methods in Medical Research. Blackwell Scientific Publications, Boston, 1994, pp. 207-228.
35. Petrinec D., Liao S., Holmes D. R.et al. Doxycycline inhibits aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92-kDa gelatinase. Journal of Vascular Surgery. 23:1996;336-346.
36. Morihara K. Production of elastase and proteinase by P. aeruginosa. Journal of Bacteriology. 88:1964;745-757.
37. Wretlind B., Pavlovskis O. R. Pseudomonas aeruginosa elastase and its role in Pseudomonas infections. Reviews of Infectious Diseases. 5(Suppl. 5):1983;S998-S1004.
38. Galloway D. R. Pseudomonas aeruginosa elastase and elastolysis revisited: recent developments. Molecular Microbiology. 5:1991;2315-2321.
39. Fukushima J., Yamamoto S., Morihara K.et al. Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase. Journal of Bacteriology. 171:1989;1698-1704.
40. Peters J. E., Galloway D. R. Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity. Journal of Bacteriology. 172:1990;2236-2240.
41. Peters J. E., Park S. J., Darzins A.et al. Further studies on Pseudomonas aeruginosa LasA: analysis of specificity. Molecular Microbiology. 6:1992;1155-1162.
42. Park S., Galloway D. R. Purification and characterization of LasD: a second staphlolytic proteinase produced by Pseudomonas aeruginosa. Molecular Microbiology. 16:1995;263-270.
43. Woods D. E., Schaffer M. S., Rabin H. R.et al. Phenotypic comparison of P. aeruginosa strains isolated from a variety of clinical sites. Journal of Clinical Microbiology. 24:1986;260-264.
44. Paakko P., Kirby M., du Bois R. M.et al. Activated neutrophils secrete stored alpha 1-antitrypsin. American Journal of Respiratory and Critical Care Medicine. 154:1996;1829-1833.
45. du Bois R. M., Bernaudin J. F., Paakko P.et al. Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin. Blood. 77:1991;2724-2730.
46. Fujita J., Nakamura H., Yamagishi Y.et al. Elevation of plasma truncated elastase alpha 1-proteinase inhibitor complexes in patients with inflammatory lung diseases. Chest. 102:1992;129-134.
47. Piano G. Infections in lower extremity vascular grafts. Surgical Clinics of North America. 75:1995;799-809.
48. Sicard, G. A., Reilly, J. M., Doblas, M. et al., Autologous vein reconstruction in prosthetic graft infections. European Journal of Vascular and Endovascular Surgery, 1997, in press.
49. Heck L. W., Morihara K., McRae W. B., Miller E. J. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase. Infection and Immunity. 51:1989;115-118.
50. Berjarano P. A., Langeveld J. P., Hudson B. G., Noelken M. E. Degradation of basement membranes by Pseudomonas aeruginosa elastase. Infection and Immunity. 57:1989;3783-3787.
51. Herron G. S., Unemori E., Wong M.et al. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arteriosclerosis and Thrombosis. 11:1991;1667-1677.
52. Newman K. M., Malon A. M., Shin R. D.et al. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connective Tissue Research. 30:1994;265-276.
53. Freestone T., Turner R. J., Coady A.et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology. 15:1995;1145-1151.
54. Thompson R. W., Parks W. C. The role of matrix metalloproteinases in abdominal aortic aneurysms. Annals of the New York Academy of Sciences. 800:1996;157-174.
55. Doring G. The role of neutrophil elastase in chronic inflammation. American Journal of Respiratory Critical Care Medicine. 150(suppl.):1994;114-117.
56. Bjorn M. J., Sokol P. A., Iglewski B. H. Influence of iron on yields of extracellular products in Pseudomonas aeruginosa cultures. Journal of Bacteriology. 138:1979;193-200.
57. Ombaka E. A., Cozens R. M., Brown M. R. W. Influence of nutrient limitation of growth on stability and production of virulence factors of mucoid and nonmucoid strains of Pseudomonas aeruginosa. Reviews of Infectious Diseases. 5(suppl. 5):1983;880-888.
58. Morihara K. Pseudolysin and other pathogen endopeptidases of thermolysin family. Methods in Enzymology. 248:1995;242-253.
59. Kessler E., Safrin M., Abrams W. R.et al. Inhibitors and specificity of Pseudomonas aeruginosa LasA. Journal of Biological Chemistry. 272:1997;9884-9889.
60. Tyagi S. C., Simon S. R. Regulation of neutrophil elastase activity by elastin-derived peptide. Journal of Biological Chemistry. 268:1993;16513-16518.
61. Meyer K. C., Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. Journal of Laboratory and Clinical Medicine. 121:1993;654-661.
62. Buret A., Cripps A. W. The immunoevasive activities of Pseudomonas aeruginosa: relevance for cystic fibrosis. American Review of Respiratory Disease. 148:1993;793-805.
63. Suter S. The role of bacterial proteases in the pathogenesis of cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 150:1994;S118-S122.
64. 1-proteinase inhibitor by proteinases from Staphlococcus aureus. Journal of Biological Chemistry. 261:1986;14330-14334.